Chemicals & fertiliser

Kazakhstan: ₸39 Billion Pharmaceutical Plant Planned for Almaty

Investors, volumes and stages of the region's major projects – for European suppliers

· 1 Source

Scroll
Chemicals & fertiliser Kazakhstan1 Source

Published · last updated · 3 Nov 2026

A new pharmaceutical plant is planned to be built in Almaty with investments of more than ₸39 billion. The project aims to expand drug production and deepen the localization of international developments within the country. The first production launches are scheduled for 2029.

The investment agreement provides for the localization of 40 international non-proprietary drug names, covering 68 production positions across 12 therapeutic areas. In the first stage, spanning 2030 to 2033, the plant will focus on the production of finished dosage forms, technology transfer, and the development of full-cycle production. Between 2029 and 2032, the production of 23 out of the 40 names is planned to be mastered. New production directions including rheumatology, immunology, and the treatment of pulmonary arterial hypertension are planned to open in 2030. The next stage, calculated for 2034 to 2036, involves organizing the production of active pharmaceutical ingredients. In 2032, the launch of six positions for biological drugs is expected, comprising five for oncology and one for hematology.

Project: Localization of pharmaceutical production in Kazakhstan · Kazakhstan · Planned · $370 m

Key facts

  • Investment volume exceeds ₸39 billion.
  • Location is Almaty, Kazakhstan.
  • First launches are scheduled for 2029.
  • Project covers 40 international non-proprietary drug names.
  • Active pharmaceutical ingredient production is planned for 2034-2036.

All sources (1)

  1. В Казахстане построят новый фармацевтический завод с инвестициями более ₸39 млрдЖайық Пресс · · RU

Imprint | Information pursuant to § 5 DDG

Company

AETEK GmbH Lindenstraße 5
63808 Haibach, Germany

Managing Director

Artur R. Pamin

Commercial Register

Amtsgericht Aschaffenburg
HRB 14157

VAT ID No.

DE288091462

EORI No.

DE644795536634916

Scan · LinkedIn